Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis

NCT03364920 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-12-07

No results posted yet for this study

Summary

This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the severity of SAP, of course the clinical outcomes. The investigators want to find some biomarkers and strategy target drugs of severe acute pancreatitis.

Conditions

  • Pancreatitis, Acute

Sponsors & Collaborators

  • Weiqin Li

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-01
Completion
2020-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03364920 on ClinicalTrials.gov